FDA Adverse Event Injury Summary report: N

G7 DUAL MOBILITY LINER 42MM E

MDR report key: 7088184 · Received December 6, 2017

Report

Report Number
0001825034-2017-10969
Event Type
Injury
Date Received
December 6, 2017
Date of Event
November 17, 2017
Report Date
December 6, 2017
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWY
PMA / PMN Number
PK150522
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CMP-(B)(4). (B)(4). CONCOMITANT MEDICAL PRODUCTS EP-200148 ACT ARTIC E1 HIP BRG 28 X 42 MM, LOT 305760; 010001001 G7 SCREW 6.5 MM X 40 MM, LOT # 6033599; 010000663 G7 PPS LTD ACET SHELL 52E, LOT # 6057951; 010000999 G7 SCREW 6.5 MM X 30 MM, LOT # 6120428; 010001000 G7 SCREW 6.5 MM X 35 MM, LOT # 3823755. REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. DHR WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. REVIEW OF THE COMPLAINT HISTORY DETERMINED THAT NO FURTHER ACTION IS REQUIRED AS NO WERE TRENDS IDENTIFIED. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. THERE ARE WARNINGS IN THE PACKAGE INSERT THAT THIS TYPE OF EVENT CAN OCCUR AND RISKS ARE ADDRESSED IN THE ASSOCIATED RISK DOCUMENTATION. THESE DEVICES WERE USED WITH A DEPUY HEAD AND STEM ZIMMER-BIOMET HAS NOT ASSESSED OR CONFIRMED THE COMPATIBILITY OF THIS COMBINATION OF DEVICES, AND THIS WOULD BE CONSIDERED AN OFF-LABEL USE OF THESE DEVICES. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT WAS REVISED DUE TO DISLOCATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
866033 G7 DUAL MOBILITY LINER 42MM E HIP PROTHSESIS KWY ZIMMER BIOMET, INC. N/A 590370

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| R